Clinigen Group plc (AIM: CLIN, 'Clinigen' or the 'Group'), the global pharmaceutical and services company, announces that it has been named as one of the most inspiring companies in Britain, following its inclusion in the London Stock Exchange Group's ('LSEG') '1,000 Companies to Inspire Britain'.

The list, which has been endorsed by Prime Minister Theresa May, identifies the UK's most dynamic SMEs and high growth potential companies, highlighting the best of British small business. Comprising of small and medium size businesses all over the UK from a range of sectors, these companies have been chosen on the basis of strong financial performance over a minimum of three years, benchmarked against competitors and significantly outperforming them.

Shaun Chilton, Group Chief Executive Officer of Clinigen, said:

'Being recognised as one of the leading 1,000 companies in the UK is extremely gratifying, and highlights the work we continue to do as a Group to grow our business. Over the coming year, we will work to ensure we maintain our position as one of the most exciting and dynamic companies in the UK. However, underlying our business is our aim to provide access to hard-to-source medicines to physicians and hospital pharmacists, for specific patients who desperately need them.'

Xavier Rolet, Chief Executive, London Stock Exchange Group said:

'LSEG's '1,000 Companies to Inspire Britain' report continues to highlight the entrepreneurial and ambitious businesses across the country that are boosting UK productivity, driving economic growth and creating jobs. These companies are the very heart of an 'anti-fragile' economy: more robust; more flexible and less prone to boom and bust.'

- Ends -

Clinigen Group plc published this content on 30 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 30 June 2017 09:46:06 UTC.

Original documenthttp://www.clinigengroup.com/media/news/clinigen-named-one-of-most-inspiring-companies-britain

Public permalinkhttp://www.publicnow.com/view/CB5FEBEAF00C448294DCEF645767EFB41F6F51CE